ESSA Pharma Inc. (EPIX) Financial Statements
ESSA Pharma Inc. (EPIX) files with the U.S. Securities and Exchange Commission under CIK 0001633932. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2024
- Net Income
- -$28.54 million
- Total Assets
- $128.11 million
- Net Cash from Operations
- -$22.72 million
Fiscal year ended Sep 30, 2024. Latest periodic SEC filing: Aug 13, 2025. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for EPIX in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History